Mine otse sisu juurde
Inimese skeletilihasrakud (HSKMC)
Kude
Skeletal muscle
Haigus
Normal skeletal muscle (non-tumorigenic primary myoblasts)
Metastaaside asukoht
Not applicable (normal, non-tumorigenic primary cell)
Sünonüümid
SkMC, HSKMC, Human skeletal muscle cells, provitro 1210691

Dokumendid

Inimese skeletilihasrakud (HSKMC)

Primary cell · Toote number 300689

Lihasrakud ainevahetuse ja treeningu uurimiseks

€1,220.00ilma käibemaksu ja saatmiskuludeta

Kohandamine / Soovitused

Tellimusel valmistatud
1

01Üldine teave

Kirjeldus

Primary Human Skeletal Muscle Cells (SkMC) are isolated from skeletal muscle and differentiate into myotubes in serum-free Skeletal Muscle Cell Differentiation Medium. They are used to study insulin resistance, exercise physiology and drug effects in 3D muscle tissue.

In culture, the cells proliferate as myoblasts and fuse into multinucleated myotubes after switching to differentiation medium. Because they are not immortalized and retain the donor's human genetic background, they offer a physiologically relevant alternative to rodent cell lines, and their metabolic profile can be further matured, for example by electrical pulse stimulation.

Kude
Skeletal muscle
Haigus
Normal skeletal muscle (non-tumorigenic primary myoblasts)
Metastaaside asukoht
Not applicable (normal, non-tumorigenic primary cell)
Rakendused
Insulin resistance and type 2 diabetes (glucose uptake, insulin signaling); In vitro exercise model: electrical pulse stimulation, contraction, GLUT4 and oxidative metabolism; Muscle energy metabolism in obesity and type 2 diabetes using human myotubes; Fatty acid oxidation and mitochondrial biogenesis (PGC-1α); 3D engineered muscle (myobundles) for drug-induced mitochondrial toxicity
Sünonüümid
  • SkMC
  • HSKMC
  • Human skeletal muscle cells
  • provitro 1210691

02Annetaja

Doonori vanus
Lot-specific (see CoA)
Etniline kuuluvus
Lot-specific (see CoA)

03Klassifikatsioon

Organism
Inimene
Sugu
Kogupõhine
Kasvuvõime
Järgija
GMO-staatus
GMO-vaba
GMO-staatuse üksikasjad
No genetic modification; normal primary human skeletal muscle cells. Not transformed or immortalized.
Bioloogilise ohutuse tase
1

04Omadused

Morfoloogia
Spindle-shaped myoblasts; multinucleated myotubes after differentiation
Rakutüüp
Primary skeletal muscle cells (myoblasts)
Tuumorigeenne
No
Kahekordistumisaeg
Lot-specific (refer to batch CoA)

05Käsitlemine ja kasvatamine

Kasvatuskeskkond
Skeletal Muscle Cell Growth Medium kit (Cytion article number 850082); Skeletal Muscle Cell Growth Medium mix (Cytion article number 850081); Skeletal Muscle Cell Differentiation Medium kit (Cytion article number 850087)
Inkubatsiooni keskkond

37°C, 5% CO2, saturated humidity.

Toidulisandid
Primary Skeletal Cell Muscle Growth Kit (ATCC PCS-950-040) pre-formulated into basal medium; no additional serum supplement required. For differentiation: PCS-950-050 standalone (no further supplements).
Dissotsiatsioonireaktiiv
Subculture reagents as recommended on the certificate of analysis
Kultuuri edasikasvatamine

Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

Jagamissuhe
2,500 to 5,000 cells/cm² (ATCC recommended seeding density)
Külvitihedus
More than 4,000 cells/cm²
Vedeliku vahetus
24 hours after seeding, then every 48 to 72 hours
Taastumine pärast sulamist

Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.

Sulatamine ja kasvatamine
  1. Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.

  2. Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Skeletal Muscle Cell Growth Medium and centrifuge at 250 × g for 5 minutes.

  3. Remove the supernatant and resuspend the cell pellet in 10 ml of Skeletal Muscle Cell Growth Medium. Check cell number and viability.

  4. Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.

  5. Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.

  6. Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.

  7. Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.

  8. Recommended seeding density: more than 4,000 cells/cm².

06Kvaliteedikontroll ja krüokonserveerimine

Viljatus

Mycoplasma contamination is excluded by PCR.

To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.

Külmutuskeskkond
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Säilitamistingimused

For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.

Tarne- ja kohaletoimetamistingimused

Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.

07Avaldumine ja vastuvõtlikkus

Valgu ekspressioon
Desmin (+) in differentiated cells (confirmed by ATCC QC)
Antigeeni ekspressioon
Von Willebrand Factor (vWF): negative (confirmed by ATCC QC)
Viirused
HIV-1: Not detected; HIV-2: Not detected; HCV: Not detected; HBV: Not detected (ATCC QC, lot-specific)

08Tunnused

Viide
Human skeletal muscle cells (HSKMC) (Cytion catalog number 300689)
NCBI maksukood
9606
Cellosaurus
Not assigned